Triamcinolone Acetonide topical preparations are indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, including atopic dermatitis, contact dermatitis, eczematous dermatitis, neurodermatitis, seborrheic dermatitis, insect bites, lichen simplex chronicus, exfoliative dermatitis, stasis dermatitis, nummular eczema, psoriasis, and pruritus ani and vulvae.

Triamcinolone Acetonide, a derivative of triamcinolone, is formulated in a suitable base for topical application. Topical corticosteroids exert their therapeutic effects primarily through anti-inflammatory, antipruritic, and vasoconstrictive actions.

A small amount of Triamcinolone is gently rub to the affected area 1-2 times daily. Some cases of eczematised psoriasis may be treated more effectively by the application of Triamcinolone under an occlusive dressing.

Occlusive dressing technique: Gently rub a small amount of Triamcinolone on the lesion until it disappears. Then reapply, leaving a thin coating and cover with a pliable non porous film. For convenience apply Triamcinolone intermittently (12 hour occlusion during the night) followed by reapplication without occlusion, during the day.

Pediatric use: Triamcinolone should not be used in children under 8 years. Administration of topical corticosteroids to children should be limited to the least amount compatible with an effective therapeutic regimen. Chronic corticosteroid therapy may interfere with the growth and development of children. As children are more likely to get side effects, they should not normally be treated for longer than 5 days.

Triamcinolone Acetonide is contraindicated in patients with known hypersensitivity to any component of the formulation. It is also contraindicated in cutaneous tuberculosis, fungal infections, viral skin infections (such as herpes simplex, varicella/chickenpox, and vaccinia), perioral dermatitis, rosacea, and ulcerative skin conditions.

The following local adverse reactions have been reported with topical corticosteroids, whether used with or without occlusive dressings: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, skin atrophy, striae, and miliaria.

There are no adequate and well-controlled studies evaluating the teratogenic effects of topically applied corticosteroids in pregnant women. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

It is not known whether topical administration of corticosteroids results in sufficient systemic absorption to produce detectable amounts in breast milk. Systemically administered corticosteroids are excreted into breast milk in quantities unlikely to cause harm to the infant. Nevertheless, caution should be exercised when topical corticosteroids are used by a nursing woman.

If adverse reactions or hypersensitivity occur, Triamcinolone Acetonide should be discontinued. Topical corticosteroids should be used cautiously on infected areas, with careful monitoring due to the risk of masking or exacerbating infections. Discontinuation of steroid therapy and/or initiation of appropriate antimicrobial treatment may be necessary.

Triamcinolone Acetonide should not be applied to healthy skin, large surface areas, or the eyes, as there is a potential risk of glaucoma and cataract formation. Prolonged use (longer than four weeks) may increase the likelihood of developing skin atrophy and striae. Extended application to flexural or intertriginous areas should be avoided.

Pediatric patients may absorb proportionally greater amounts of topical corticosteroids and are therefore at increased risk of systemic toxicity. Long-term continuous use in infants should be avoided. Adrenal suppression may occur even in the absence of occlusive dressings.

Topically applied corticosteroids may be absorbed in sufficient quantities to produce systemic effects, including mild and reversible suppression of adrenal function. Other potential systemic effects include skin ecchymosis, peptic ulceration, hypertension, worsening of infections, hirsutism, acne, edema, and muscle weakness.

Corticosteroid, Glucocorticoids, Triamcinolone & Combined preparations.

Store in a cool, dry place. Protect from light.